Nobel Prize for revolutionising medicine

The biggest prize in medical science has been won by two scientists who have pioneered a genetic technique that promises to revolutionise medicine in the 21st century.

This year's Nobel Prize for Medicine has been awarded for the discovery of RNA interference (RNAi) - a naturally occurring process for switching off specific genes.

Scientists are already using the technique routinely as a highly effective research tool, but the wider interest comes from RNAi's potential medical applications. Specialists believe RNAi could be used to develop radical new treatments for a variety of incurable disorders from Huntington's disease and certain forms of blindness to heart disease, diabetes and cancer.

Andrew Fire, 47, of Stanford University in California, and Craig Mello, 45, of the University of Massachusetts Medical School, were told yesterday that they would share the £800,000 prize money for identifying and naming RNAi in a scientific paper published in the journal Nature in 1998.

Professor Mello said yesterday that they were both still relatively young for receiving a Nobel Prize, which came sooner than expected given that many previous Nobel laureates have had to wait decades for recognition. "I knew it was a possibility, but I didn't really expect it for perhaps a few more years. Both Andrew and I are fairly young, 40 or so, and it's only been about eight years since the discovery," Professor Mello said.

Professor Fire, who worked at the Carnegie Institution in Washington when the research was carried out, said that the breakthrough would not have happened without other people's involvement. "Science is a group effort. Please recognise that the recent progress in the field of RNA-based gene silencing has involved original scientific inquiry from research groups around the world," he said.

The original observations that led to the discovery go back to 1990, when Richard Jorgensen of the University of Arizona in Tucson noticed that he could turn purple petunia flowers white by injecting them with a gene for pigment coloration.

Professor Jorgensen called the process "co-suppression", but the mechanism remained elusive until Professors Fire and Mello carried out their own studies in the laboratory using a microscopic nematode worm. They found they could switch off or "silence" particular genes in the worm by injecting it with double-stranded fragments of a molecule called RNA - which closely resembles the DNA blueprint of life.

The Nobel Assembly at the Karolinska Institute in Stockholm said: "Although it was evident RNA played a key role in gene silencing, the phenomenon remained enigmatic until the discovery of RNA interference provided a most unexpected explanation with many profound consequences. It was evident from the very beginning that the significance of the discovery of RNAi would be exceptional."

Further work has shown that RNAi appears to be a ubiquitous process in living organisms. In 2002, scientists demonstrated that it also works in human cells. This led to speculation that it might be possible to turn off diseased genes that cause cancer or inherited disorders such as Huntington's, or that RNAi could be adapted to sabotage the vital genes of viruses such as HIV.

Professor Chris Higgins, director of the Medical Research Council's Clinical Sciences Centre in London, said that the discovery of RNAi has revolutionised the understanding of how genes can be controlled. "Perhaps even more importantly, it provides a simple tool for manipulating gene expression in the laboratory, and with great promise for altering gene expression to treat diseases such as viral infections and cancer," Professor Higgins said.

Drug companies such as GlaxoSmithKline and Pfizer have already taken out licenses on various RNAi techniques in the hope of developing new therapies.

Disease battlegrounds

* Blindness: Two biotechnology companies, Sirna of Boulder, Colorado, and Acuity, of Philadelphia, are conducting clinical trials involving patients with macular degeneration. RNAi could block the growth of harmful blood vessels in the eye that cause visual impairment.

* Huntington's disease: RNAi is being considered as a way of turning off the gene that causes Huntington's.

* HIV and Aids: Scientists hope to disable the Aids virus by silencing one of the genes it needs for replication.

* Heart disease: If scientists can switch off a gene involved in the build-up of cholesterol in the body they might be able to treat people who are born with very high levels of this damaging fat.

* Cancer: RNAi could be adapted to silence cancer-causing genes. Test-tube studies have proved successful.

Start your day with The Independent, sign up for daily news emails
There will be a chance to bid for a rare example of the SAS Diary, collated by a former member of the regiment in the aftermath of World War II but only published – in a limited run of just 5,000 – in 2011
charity appealTime is running out to secure your favourite lot as our auction closes at 2pm today
File: James Woods attends the 52nd New York Film Festival at Walter Reade Theater on September 27, 2014
peopleActor was tweeting in wake of NYPD police shooting
Martin Skrtel heads in the dramatic equaliser
SPORTLiverpool vs Arsenal match report: Bandaged Martin Skrtel heads home in the 97th-minute
Billie Whitelaw was best known for her close collaboration with playwright Samuel Beckett, here performing in a Beckett Trilogy at The Riverside Studios, Hammersmith
people'Omen' star was best known for stage work with Samuel Beckett
ebooksA year of political gossip, levity and intrigue from the sharpest pen in Westminster
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Recruitment Genius: Telesales & Customer Service Executives - Outbound & Inbound

£7 - £9 per hour: Recruitment Genius: Are you outgoing? Do you want to work in...

Recruitment Genius: National Account Manager / Key Account Sales

£30000 - £35000 per annum: Recruitment Genius: An opportunity has arisen for a...

Recruitment Genius: Operations Manager

£30000 - £35000 per annum: Recruitment Genius: An exciting opportunity to join...

Recruitment Genius: Recruitment Consultant

£30000 - £35000 per annum: Recruitment Genius: We have an excellent role for a...

Day In a Page

Surrounded by high-rise flats is a little house filled with Lebanon’s history - clocks, rifles, frogmen’s uniforms and colonial helmets

Clocks, rifles, swords, frogmen’s uniforms

Surrounded by high-rise flats is a little house filled with Lebanon’s history
Return to Gaza: Four months on, the wounds left by Israel's bombardment have not yet healed

Four months after the bombardment, Gaza’s wounds are yet to heal

Kim Sengupta is reunited with a man whose plight mirrors the suffering of the Palestinian people
Gastric surgery: Is it really the answer to the UK's obesity epidemic?

Is gastric surgery really the answer to the UK's obesity epidemic?

Critics argue that it’s crazy to operate on healthy people just to stop them eating
Homeless Veterans appeal: Christmas charity auction Part 2 - now LIVE

Homeless Veterans appeal: Christmas charity auction

Bid on original art, or trips of a lifetime to Africa or the 'Corrie' set, and help Homeless Veterans
Pantomime rings the changes to welcome autistic theatre-goers

Autism-friendly theatre

Pantomime leads the pack in quest to welcome all
The week Hollywood got scared and had to grow up a bit

The week Hollywood got scared and had to grow up a bit

Sony suffered a chorus of disapproval after it withdrew 'The Interview', but it's not too late for it to take a stand, says Joan Smith
From Widow Twankey to Mother Goose, how do the men who play panto dames get themselves ready for the performance of a lifetime?

Panto dames: before and after

From Widow Twankey to Mother Goose, how do the men who play panto dames get themselves ready for the performance of a lifetime?
Thirties murder mystery novel is surprise runaway Christmas hit

Thirties murder mystery novel is surprise runaway Christmas hit

Booksellers say readers are turning away from dark modern thrillers and back to the golden age of crime writing
Anne-Marie Huby: 'Charities deserve the best,' says founder of JustGiving

Anne-Marie Huby: 'Charities deserve the best'

Ten million of us have used the JustGiving website to donate to good causes. Its co-founder says that being dynamic is as important as being kind
The botanist who hunts for giant trees at Kew Gardens

The man who hunts giants

A Kew Gardens botanist has found 25 new large tree species - and he's sure there are more out there
The 12 ways of Christmas: Spare a thought for those who will be working to keep others safe during the festive season

The 12 ways of Christmas

We speak to a dozen people who will be working to keep others safe, happy and healthy over the holidays
Birdwatching men have a lot in common with their feathered friends, new study shows

The male exhibits strange behaviour

A new study shows that birdwatching men have a lot in common with their feathered friends...
Diaries of Evelyn Waugh, Virginia Woolf and Noël Coward reveal how they coped with the December blues

Famous diaries: Christmas week in history

Noël Coward parties into the night, Alan Clark bemoans the cost of servants, Evelyn Waugh ponders his drinking…
From noble to narky, the fall of the open letter

From noble to narky, the fall of the open letter

The great tradition of St Paul and Zola reached its nadir with a hungry worker's rant to Russell Brand, says DJ Taylor
A Christmas ghost story by Alison Moore: A prodigal daughter has a breakthrough

A Christmas ghost story by Alison Moore

The story was published earlier this month in 'Poor Souls' Light: Seven Curious Tales'